AumniVIDA

Outlive and Medicine 3.0 (Peter Attia)

Strength, fitness, sleep and diabetes preventionWell acceptedLowering apoB earlier and further than guidelinesPromisingHigh protein targets and Zone 2 emphasisDebatedExtensive early screeningDebatedPartly open to evidenceUpdated October 31, 2026 · 22 studies · Written by the AumniVIDA teamUnits

What is outlive and medicine 3.0 (peter attia)?

Outlive is physician Peter Attia's 2023 book on Medicine 3.0, a prevention-first approach to longevity. It targets the four horsemen (heart disease, cancer, neurodegeneration and metabolic disease) with exercise as the main lever: stability, strength, Zone 2 and VO2max training, plus nutrition, sleep, emotional health and early, aggressive lipid lowering.

Flat illustration of an older adult climbing a flight of outdoor steps while carrying two grocery bags.
Outlive asks readers to train now for the physical tasks they want to manage in their last decade, such as carrying groceries up stairs.

Rated by what it asks you to do. Training for strength and fitness, sleeping well and preventing diabetes match strong mainstream evidence, and lowering apoB earlier and further than guidelines rests on strong genetic evidence but no long trials in low-risk people. High protein targets, the special status of Zone 2 and extensive screening that can find harmless problems are debated, and nutrition researchers say the book gives cohort evidence on diet less weight than it deserves. Drugs and fasts Attia has tried on himself, such as rapamycin, metformin and week-long water fasts, are listed separately as his experiments and do not count here.

The rules

The rules ofOutlive and Medicine 3.0 (Peter Attia)

Debated in mainstream science8 rules
  1. 1Organize long-term risk around the four horsemen: atherosclerotic cardiovascular disease, cancer, neurodegenerative disease and metabolic disease.
  2. 2Start prevention decades before disease, weighing the risk of acting against the risk of waiting.
  3. 3Train all four pillars every week: stability, strength, Zone 2 aerobic base (lactate below about 2 mmol/L) and VO2max intervals.
  4. 4Plan training around a centenarian decathlon: the specific physical tasks you want to manage in your last decade.
  5. 5Eat for adequate protein and appropriate energy intake, adjusting to your own data rather than following a named diet.
  6. 6Lower apoB and LDL early and aggressively when risk justifies it, with a clinician.
  7. 7Treat sleep and emotional health as pillars, not afterthoughts.
  8. 8Use medications, such as lipid-lowering drugs, where risk and evidence justify them, with a prescriber.

Share these rules as an image or a link.

Common variants
Outlive as writtenThe full framework from the 2023 book, delivered through a clinician who orders extensive testing and coaching.
Time-limited trainingAttia's 2026 split for about 2 hours a week: two high-intensity sessions with short Zone 2 warm-ups, plus strength work.
High-volume trainingAbout 6 or more hours a week: roughly 4 hours of Zone 2 and 2 hours of harder work, or an 80:20 easy to hard split above 7 to 8 hours.
AumniVIDA Attia-styleA scorecard applying the centenarian decathlon, four horsemen and training pillars to your data, with protein of at least 1.6 g/kg a day and added sugar of at most 5% of energy.

What it aims to do

  • Delay or prevent the four main chronic diseases of aging.
  • Extend healthspan: physical, cognitive and emotional function in later life.
  • Build enough strength, aerobic capacity and stability to stay independent into the last decade.
  • Keep lifetime exposure to apoB-carrying lipoproteins low.
  • Catch metabolic dysfunction and cancer early.

What it claims, and what the evidence shows

Grades reflect evidence in people. Animal and cell results alone never earn more than limited.

  • Lifespan and mortality

    Moderate evidence

    Exercise is the most potent tool for living longer

    Fitness and strength strongly predict survival in large cohorts, but a 5-year randomized exercise trial in older adults did not lower mortality compared with guideline activity. [2][9][10][8]

  • Heart and blood vessels

    Strong evidence

    Early, aggressive apoB and LDL lowering prevents heart disease

    Trials show each 1 mmol/L lower LDL cuts major vascular events by 22%, and genetics shows lifelong lower LDL protects about three times more, though no trial has treated young low-risk people for decades. [3][4][11][12]

  • Cardiorespiratory fitness

    Moderate evidence

    Zone 2 and VO2max training raise cardiorespiratory fitness

    Endurance training and intervals both raise VO2max by about 5 mL/kg/min, but evidence does not support Zone 2 as uniquely effective for mitochondria. [5][13][6]

  • Muscle and strength

    Strong evidence

    Strength training and enough protein preserve muscle and function

    Strength training builds muscle, protein adds to gains up to about 1.62 g/kg a day, and grip strength and strength training predict lower mortality. [10][14][15]

  • Blood sugar and insulin

    Strong evidence

    Exercise and nutrition prevent metabolic disease

    A lifestyle program with 7% weight loss and 150 minutes of activity a week cut new type 2 diabetes by 58% in a large randomized trial. [16]

  • Cancer risk

    Mixed evidence

    Earlier and more frequent screening lowers cancer deaths

    Screening can reduce some cancers, but one colonoscopy invitation cut colorectal cancer by 18% without a significant drop in colorectal cancer death or overall mortality. [7]

  • Sleep

    Moderate evidence

    Adequate sleep protects long-term health

    Short and long sleep are both linked to higher mortality in 1.4 million people, but the evidence is observational. [17]

  • Mood and stress

    Moderate evidence

    Emotional health and relationships are part of longevity

    Stronger social relationships are linked to 50% greater odds of survival across 148 studies, an observational finding. [18]

How it handles evidence

As presented by Peter Attia. Three checks you can verify from the sources, separate from the evidence ratings above.

Partly open to evidence

  • Separates its advice from experimentsPartly

    He discusses drugs he has tried apart from what he prescribes, and in September 2023 stressed his reservations about giving rapamycin widely to patients. His own routine and his general advice often come up in the same interviews, so readers have to tell the two apart.

    The Drive #272, Rapamycin: potential longevity benefits, surge in popularity, unanswered questions (September 2023)

  • Says how strong the evidence is for each recommendationPartly

    Outlive explains the gap between trial and cohort evidence but does not grade each recommendation, and a December 2024 Red Pen Reviews check found it dismisses nutrition cohort studies while leaning on them for protein and misstates two cited studies. On his podcast he now sorts interventions as proven, promising, fuzzy, noise or nonsense, for example rapamycin as promising in May 2024.

    Red Pen Reviews, Outlive (December 2024)

  • Has publicly changed its advice when the evidence changedYes

    He has publicly changed course several times: he stopped metformin in 2019 after 9 years, dropped long water fasts after a 2021 scan showed muscle loss, and in October 2026 set out how his views on fasting, keto, metformin, rapamycin, whole-body MRI and Zone 2 had changed.

    The Drive #411, AMA #90: Strong convictions, loosely held (October 2026)

Key takeaways

  1. 1

    Outlive organizes prevention around four chronic diseases, which Attia says cause over 80% of deaths in nonsmokers over 50 [1].

  2. 2

    Low fitness carried a death risk five times that of elite fitness in 122,007 adults, more than smoking or diabetes, though this is observational [2].

  3. 3

    Lowering LDL by 1 mmol/L cuts major vascular events by 22% in trials, and lifelong lower LDL protects about three times more [3] [4].

  4. 4

    Zone 2 is useful volume but not uniquely effective; intervals raise VO2max as well or better [5] [6].

  5. 5

    The weakest parts are the claims that most depend on extra testing: screening benefits are modest and exercise has not lowered mortality in a large trial [7] [8].

What is Outlive and Medicine 3.0?

Outlive (2023) is physician Peter Attia's book, written with journalist Bill Gifford, arguing for Medicine 3.0: prevention that starts decades before disease, is tailored to the person and aims at healthspan as well as lifespan. Its tools are exercise, nutrition, sleep, emotional health and, where warranted, drugs and supplements.

Peter Attia trained in medicine at Stanford and in surgery at Johns Hopkins, founded the clinic Early Medical and hosts The Drive podcast. His site frames longevity as a balance of lifespan and healthspan, and puts it simply: to live longer you have to live longer without chronic disease [1].

In the book, Medicine 3.0 is set against standard care, which tends to treat diseases once they are diagnosed. Medicine 3.0 is meant to:

  • Act early. Start reducing risk in your 30s and 40s for diseases that kill in your 70s and 80s.
  • Be personal. Tailor screening, training and diet to the individual's risks and data.
  • Accept risk trade-offs. Weigh the risks of acting against the risks of waiting, rather than waiting for certainty.
  • Target healthspan. Protect physical, cognitive and emotional function, not only years of life.

Outlive calls its levers tactics: exercise, nutrition, sleep, emotional health and medications and supplements [1]. Exercise gets the most space.

Peter Attia has not reviewed or endorsed this page, and AumniVIDA is not affiliated with him. We summarize the framework from the book's own page and his published articles, and grade each pillar against independent research. Outlive is a book of arguments, so it sits in the hypotheses tier of our evidence rows; the studies it draws on are graded separately.

What are the four horsemen in Outlive?

The four horsemen are atherosclerotic cardiovascular disease, cancer, neurodegenerative disease such as Alzheimer's, and metabolic disease such as type 2 diabetes. Attia writes that together they account for over 80% of deaths in nonsmokers over 50, so prevention should target each one.

Organizing risk this way changes what you measure and when. The framework's main levers for each horseman, and how well each lever is supported:

HorsemanMain levers in the frameworkEvidence for the lever
Atherosclerotic diseaseLower apoB and LDL early, control blood pressure, exerciseStrong: each 1 mmol/L lower LDL cuts major vascular events by 22% in trials [3]
CancerAvoid smoking, keep metabolic health, screen earlyMixed for screening: one colonoscopy invitation cut colorectal cancer by 18% but not overall deaths [7]
Neurodegenerative diseaseExercise, sleep, vascular and metabolic healthMostly observational
Metabolic diseaseExercise, weight and dietStrong: a lifestyle program cut new diabetes by 58% [16]

Metabolic dysfunction runs through the other three: insulin resistance raises cardiovascular, cancer and dementia risk, which is why the framework treats it early. Markers that speak to each horseman include ApoB, Lp(a) and LDL cholesterol for the heart, and HbA1c, fasting insulin and triglycerides for metabolic health.

The four horsemen and the levers for each

Atherosclerotic disease

Markers: ApoB, LDL cholesterol, Lp(a)

  • Lower apoB and LDL early. Strong: each 1 mmol/L lower cut major vascular events 22% in trials
  • Control blood pressure
  • Exercise

Cancer

Evidence for screening: mixed

  • Avoid smoking
  • Keep metabolic health
  • Screen early. One colonoscopy invitation cut colorectal cancer 18% but not overall deaths

Neurodegenerative disease

Evidence for the levers: mostly observational

  • Exercise
  • Sleep
  • Vascular and metabolic health

Metabolic disease

Markers: HbA1c, fasting insulin, triglycerides

  • Exercise
  • Weight and diet. Strong: a lifestyle program cut new diabetes by 58%

Attia writes that the four cause over 80% of deaths in nonsmokers over 50. Exercise, sleep, nutrition and emotional health act on all four, and the framework treats exercise as the main lever.

Outlive groups long-term risk into four chronic diseases and matches each with prevention levers. Evidence strength differs by lever.

Why does Attia call exercise the most powerful longevity drug?

Because fitness and strength predict survival more strongly than most risk factors. In 122,007 adults, low treadmill fitness carried five times the death risk of elite fitness, more than smoking or diabetes. Trials show exercise improves risk factors, but a 5-year trial in older adults did not lower mortality.

The book's case rests largely on cohort data. In a Cleveland Clinic cohort of 122,007 adults, the adjusted hazard ratio for death was 5.04 for the least fit compared with the most fit, against 1.41 for smoking and 1.40 for diabetes [2]. A meta-analysis of 33 cohorts found each extra 1 MET of fitness linked to 13% lower mortality [9]. For strength, each 5 kg lower grip strength was linked to 16% higher mortality in 17 countries [15], and muscle-strengthening activity to 10% to 17% lower mortality [10].

The caveat: fitness is partly inherited and partly a sign of health, so these cohorts cannot prove that training more will add years. The best randomized test, Generation 100, assigned 1,567 Norwegians around 73 to 5 years of supervised exercise; mortality did not differ from people following activity guidelines, though the high-intensity group showed a nonsignificant trend toward fewer deaths [8]. Many controls also exercised, which narrowed the contrast.

The centenarian decathlon. Attia's planning tool asks you to list the physical tasks you want to manage in your last decade, such as carrying groceries upstairs or lifting a grandchild, and to train now with enough margin for decline. It turns a vague goal into specific capacities: strength, aerobic capacity, balance and joint stability.

Risk of death: low fitness compared with common risk factors

Show the data
Risk of death: low fitness compared with common risk factors
ItemValue (hazard ratio for death)LowHighNote
Low vs elite fitness5.044.16.2
Below vs above average fitness1.411.341.49
Smoking1.411.361.46
Diabetes1.41.341.46
Coronary artery disease1.291.241.35
Adjusted hazard ratios for all-cause death among 122,007 adults who had treadmill tests. Low fitness compared with elite fitness carried a larger risk than smoking or diabetes. Source: Mandsager 2018.

How does Outlive structure training: stability, strength, Zone 2 and VO2max?

Attia's training has four pillars: stability as the foundation, strength, an aerobic base in Zone 2 (lactate under about 2 mmol/L) and VO2max work with short hard intervals. His 2026 guidance splits aerobic time by the hours available, such as about 4 hours of Zone 2 and 2 hours of harder work in a 6-hour week.

Stability covers balance, control and joint health, which Attia treats as the base that makes the other three safer [1]. Strength focuses on preserving muscle and grip with age; see strength training.

Zone 2 is the highest sustained effort at which blood lactate stays below about 2 mmol/L, or roughly a pace where you can speak in full sentences but would rather not chat [19]. The idea draws on lactate research showing that elite endurance athletes burn more fat and produce less lactate at a given effort than less fit people [13]. See Zone 2 cardio.

VO2max training uses short, hard intervals near maximum effort; the Norwegian 4x4 is a common format. Both continuous training and intervals raise VO2max by about 5 mL/kg/min compared with no exercise [5].

Attia's 2026 article reframes Zone 2 as a means to an end [19]:

Weekly timeSuggested split
About 2 hoursTwo high-intensity sessions, each with a 10 to 15 minute Zone 2 warm-up
About 6 hoursAbout 4 hours Zone 2, 2 hours harder work
7 to 8 hours or moreRoughly 80% easy, 20% hard

The main scientific pushback is about Zone 2. A 2025 review by exercise physiologists including Martin Gibala concluded that evidence does not support Zone 2 as the best intensity for building mitochondria, and that harder work matters more when time is short [6]. Attia's newer guidance moves in the same direction for people with little time.

Stability, strength, Zone 2 and VO2max by weekly time budget

  1. Step 1

    About 2 hours a week

    2 hard sessions

    Each with a 10 to 15 minute Zone 2 warm-up.

  2. Step 2

    About 6 hours a week

    4 h Zone 2, 2 h harder

    Zone 2 is the highest effort with lactate below about 2 mmol/L.

  3. Step 3

    7 to 8 hours or more

    About 80% easy, 20% hard

    The classic endurance split once time allows.

The splits sit on four pillars: stability as the base, then strength, Zone 2 and VO2max intervals such as the Norwegian 4x4. Strength training is linked to lower mortality in cohort data.

Attia's four training pillars, and how his 2026 guidance divides aerobic time by the hours available.

Why does Attia push early, aggressive lipid management?

Because apoB-carrying particles such as LDL cause atherosclerosis and the damage builds over decades. Genetic studies show that lifelong lower LDL cuts heart disease risk about three times more per unit than statins started later, so Attia favors lowering apoB based on risk, years before plaque or symptoms appear.

A European Atherosclerosis Society panel concluded in 2017 that LDL particles cause atherosclerotic cardiovascular disease and that risk tracks cumulative exposure [11]. The strongest support for starting early is genetic: variants that lower LDL from birth cut coronary heart disease risk by 54.5% per 38.7 mg/dL (1 mmol/L)1 mmol/L (38.7 mg/dL), about three times the effect of statins started in mid-life [4].

Trials confirm that lowering LDL helps at any starting level tested. Each 1 mmol/L reduction cut major vascular events by 22% and all-cause mortality by 10% across 26 statin trials [3]. Adding evolocumab to statins took LDL to a median 30 mg/dL (0.78 mmol/L)0.78 mmol/L (30 mg/dL) and cut events by a further 15% in people with heart disease [12].

Attia's 2026 article argues that very high LDL is a problem to address, not a gamble, even in people whose LDL rises on a ketogenic diet, and that treatment should follow risk rather than wait for imaging [20].

Where the evidence stops. No trial has started drugs in healthy people in their 30s and followed them for decades, so the case for very early treatment combines genetics with shorter trials in higher-risk people. Guidelines still base treatment on estimated 10-year or lifetime risk. Read more on the ApoB and Lp(a) hubs, and discuss treatment with your clinician.

Illustration of an artery cross-section with small spherical lipoprotein particles crossing the inner lining and gathering in the wall.
Each LDL and related particle carries one apoB protein; particles that slip into the artery wall and are retained start plaque.

What does Outlive say about nutrition, sleep and emotional health?

Outlive treats the choice of named diet as the wrong question and focuses on nutritional biochemistry: enough protein, appropriate energy intake and using your own data to adjust. It treats sleep and emotional health as pillars in their own right, arguing that ignoring emotional health while chasing longevity is a serious mistake.

Nutrition. The book's page frames diets as the wrong focus and favors adjusting what you eat to your own biomarkers and body composition [1]. Protein is the most concrete target in Attia-style plans. Protein added to strength training increases muscle and strength, with no further gain in fat-free mass above about 1.62 g/kg a day [14]. AumniVIDA's Attia-style protocol uses 1.6 g/kg a day as its protein floor; see high-protein diets. For preventing metabolic disease, lifestyle change with modest weight loss and 150 minutes of activity a week cut new diabetes by 58%, almost twice the effect of metformin [16].

Sleep. Both short and long sleep are linked to higher mortality, by 12% and 30% respectively, in pooled cohorts of 1.4 million people [17]. These links are observational. Practical sleep steps overlap with morning sunlight and a regular schedule.

Emotional health. Outlive argues that neglecting emotional health while pursuing physical longevity can be a serious mistake [1]. Supporting evidence is mainly observational: stronger social relationships were linked to 50% greater odds of survival across 148 studies [18].

Medications and supplements. The framework allows drugs where risk justifies them, with lipid-lowering drugs the clearest case [11]. Candidate longevity drugs that Attia has tried on himself are a separate matter and appear in his experiments, listed below, not as advice. Their evidence is thin in people: rapamycin extends lifespan in mice [21], and metformin blunted fitness gains from aerobic training in older adults [22].

New cases of type 2 diabetes in the Diabetes Prevention Program

Show the data
New cases of type 2 diabetes in the Diabetes Prevention Program
ItemValue (cases per 100 person-years)LowHighNote
Placebo11
Metformin7.8
Lifestyle program4.87% weight loss and 150 minutes of activity a week
Cases per 100 person-years over about 3 years in adults with prediabetes. Lifestyle change beat metformin. Source: Knowler 2002.

What are the main critiques of Outlive's approach?

Critics mostly accept the exercise and lipid advice but question how far the evidence goes: Zone 2 may not be special, aggressive screening has modest proven benefit, exercise trials have not shown lower mortality, and the testing-heavy model is hard to access. Many claims rest on cohort data.

The main lines of critique, with what the evidence shows:

  1. Observational foundations. The headline exercise numbers come from cohorts in which fitness is partly a marker of good health [2]. In the largest randomized test in older adults, 5 years of exercise did not reduce mortality compared with guideline activity [8].
  2. Zone 2 overemphasis. Exercise physiologists argue that Zone 2 is not the optimal intensity for mitochondrial gains in the general public [6]. Attia's own 2026 article now presents it as one tool among several [19].
  3. Screening limits. Early and frequent screening can find cancer sooner, but trial benefits are modest. In NordICC, inviting people to one colonoscopy reduced colorectal cancer by 18% and the drop in colorectal cancer death was not statistically significant, partly because only 42% attended [7]. More testing also means more false positives and follow-up procedures.
  4. Lipid targets beyond the trials. Treating young, low-risk people very aggressively relies on genetic evidence rather than long trials in that group [4].
  5. Access. A model built on frequent advanced testing, imaging and coaching suits people with time, money and a willing clinician; the lifestyle core does not need any of that.
  6. Longevity drugs. Drugs discussed in longevity circles, such as rapamycin, rest mainly on animal data [21]. Attia's own tries with them are personal experiments, listed below, and are not part of what the book asks readers to do.

The parts with the strongest human evidence are the least controversial: train for fitness and strength, prevent diabetes through lifestyle, lower LDL in people at risk, sleep enough and keep close relationships [16] [3] [18].

How does AumniVIDA's Attia-style protocol relate to Outlive?

AumniVIDA's Attia-style protocol applies three Outlive frameworks to your data: the centenarian decathlon, the four horsemen and the four training pillars. It scores protein (at least 1.6 g/kg a day and 25 g at most meals) and added sugar (at most 5% of energy). Peter Attia has not reviewed or endorsed it.

The app's version is community-compiled from Attia's published frameworks. Its nutrition targets come from the research literature, not from Attia directly.

Outlive ideaWhat the app does
Centenarian decathlonLets you name the physical tasks you want in your last decade and track the capacities behind them
Four horsemenGroups your labs, such as ApoB, LDL, HbA1c and blood pressure, by the disease they speak to
Training pillarsUses workout data from Apple Health or Oura to show when training leans too far toward one pillar, such as plenty of Zone 2 and no strength work
NutritionScores protein of at least 1.6 g/kg a day [14], at least 25 g at most meals, and added sugar of at most 5% of energy

The app explains your data for general wellness. Decisions about lipid-lowering drugs, cancer screening and other medical tests stay with you and your clinician. For a very different, measurement-heavy personal regimen, compare Bryan Johnson's Blueprint.

The studies, by type

Strongest designs first. Scroll each row; every card links to the paper and says whether it supports the protocol.

Systematic reviews and meta-analyses (7)

  • JAMA · 2009

    [9]

    Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.

    Meta-analysis of 33 cohort studies · 102,980 healthy adults

    Each 1-MET higher fitness level was linked to 13% lower all-cause mortality, and low fitness carried a 70% higher risk of death than high fitness.

    SupportsRead
  • The Lancet · 2010

    [3]

    Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

    Individual-participant meta-analysis of 26 randomized trials · About 170,000 trial participants

    Each 38.7 mg/dL (1.0 mmol/L)1.0 mmol/L (38.7 mg/dL) reduction in LDL cholesterol cut major vascular events by 22% and all-cause mortality by 10%, including in people starting below 2 mmol/L.

    SupportsRead
  • Sports Medicine · 2015

    [5]

    Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials.

    Meta-analysis of 28 controlled trials · 723 healthy adults aged 18 to 45

    Both continuous endurance training and high-intensity intervals raised VO2max substantially compared with no exercise, by about 4.9 and 5.5 mL/kg/min.

    SupportsRead
  • British Journal of Sports Medicine · 2022

    [10]

    Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies.

    Systematic review and meta-analysis of 16 cohort studies · Adults without severe disease

    Muscle-strengthening activity was linked to 10% to 17% lower all-cause mortality, cardiovascular disease, cancer and diabetes, with the largest benefit at about 30 to 60 minutes a week.

    SupportsRead
  • British Journal of Sports Medicine · 2018

    [14]

    A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults.

    Meta-analysis of 49 randomized trials · 1,863 healthy adults

    Protein supplementation during strength training added strength and muscle, with no further gains in fat-free mass above a total intake of about 1.62 g/kg a day.

    SupportsRead
  • Sleep · 2010

    [17]

    Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies.

    Meta-analysis of 16 prospective cohort studies · 1,382,999 adults

    Both short sleep (12% higher risk) and long sleep (30% higher risk) were linked to higher mortality across 1.4 million people.

    SupportsRead
  • PLoS Medicine · 2010

    [18]

    Social relationships and mortality risk: a meta-analytic review.

    Meta-analysis of 148 studies · 308,849 participants

    People with stronger social relationships had 50% greater odds of survival over follow-up, an effect comparable with well-known risk factors.

    SupportsRead

Randomized controlled trials (5)

  • New England Journal of Medicine · 2002

    [16]

    Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

    Randomized controlled trial, mean 2.8 years (Diabetes Prevention Program) · 3,234 adults with prediabetes

    A lifestyle program with 7% weight loss and 150 minutes of activity a week cut new type 2 diabetes by 58%, beating metformin's 31%.

    SupportsRead
  • New England Journal of Medicine · 2017

    [12]

    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

    Randomized placebo-controlled trial (FOURIER) · 27,564 patients with atherosclerotic cardiovascular disease

    Adding evolocumab to a statin lowered LDL cholesterol to a median 30 mg/dL (0.78 mmol/L)0.78 mmol/L (30 mg/dL) and reduced cardiovascular events by 15%, with no rise in adverse events beyond injection-site reactions.

    SupportsRead
  • BMJ · 2020

    [8]

    Effect of exercise training for five years on all cause mortality in older adults-the Generation 100 study: randomised controlled trial.

    Randomized controlled trial, 5 years · 1,567 adults aged about 73 in Norway

    Five years of supervised exercise did not lower mortality compared with following activity guidelines, though the high-intensity interval group showed a nonsignificant trend toward lower mortality.

    Mixed resultRead
  • New England Journal of Medicine · 2022

    [7]

    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.

    Pragmatic randomized trial, 10 years (NordICC) · 84,585 adults aged 55 to 64 in Poland, Norway and Sweden

    An invitation to one screening colonoscopy cut colorectal cancer by 18% over 10 years, but the drop in colorectal cancer death was not statistically significant and overall mortality did not change; only 42% of those invited attended.

    Mixed resultRead
  • Aging Cell · 2019

    [22]

    Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults.

    Randomized double-blind placebo-controlled trial, 12 weeks · 53 adults aged about 62

    Metformin taken during 12 weeks of aerobic training blunted the gains in insulin sensitivity, VO2max and muscle mitochondrial respiration.

    Finds againstRead

Large observational studies in people (3)

  • JAMA Network Open · 2018

    [2]

    Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing.

    Retrospective cohort, median 8.4 years · 122,007 adults referred for treadmill testing in Cleveland

    Low treadmill fitness carried five times the mortality risk of elite fitness (hazard ratio 5.04), a larger gap than smoking (1.41), diabetes (1.40) or coronary artery disease (1.29).

    SupportsRead
  • The Lancet · 2015

    [15]

    Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.

    Prospective cohort in 17 countries · Adults aged 35 to 70 in 17 countries

    Each 5 kg lower grip strength was linked to 16% higher all-cause mortality and 17% higher cardiovascular mortality, a stronger predictor than systolic blood pressure.

    SupportsRead
  • Journal of the American College of Cardiology · 2012

    [4]

    Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.

    Mendelian randomization meta-analysis · 312,321 participants

    Genetic variants that lower LDL cholesterol from birth cut coronary heart disease risk by 54.5% per 1 mmol/L, about three times the reduction seen with statins started later in life.

    SupportsRead

Mechanistic studies in people (1)

  • Sports Medicine · 2018

    [13]

    Assessment of Metabolic Flexibility by Means of Measuring Blood Lactate, Fat, and Carbohydrate Oxidation Responses to Exercise in Professional Endurance Athletes and Less-Fit Individuals.

    Cross-sectional exercise physiology study · Professional cyclists, moderately active adults and adults with metabolic syndrome

    Professional endurance athletes burned more fat and produced less lactate at the same exercise intensity than moderately active people or people with metabolic syndrome, the basis for using lactate to define Zone 2.

    SupportsRead

Animal and cell studies (1)

  • Nature · 2009

    [21]

    Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

    Multi-site lifespan study in mice · Genetically heterogeneous mice

    Rapamycin started at 600 days of age extended lifespan in male and female mice, by 9% and 14% at the age of 90% mortality.

    SupportsRead

Hypotheses and expert reviews (5)

  • Book · 2023

    [1]

    Outlive: The Science and Art of Longevity

    Book setting out a prevention framework

    Frames longevity as lifespan plus healthspan, organizes risk around four chronic diseases said to cause over 80% of deaths in nonsmokers over 50, and calls exercise the most potent pro-longevity drug.

    SupportsRead
  • peterattiamd.com · 2026

    [19]

    A better way to think about Zone 2

    Expert article

    Defines the top of Zone 2 as roughly 2 mmol/L blood lactate, suggests a talk test, and splits weekly training by time available, for example about 4 hours of Zone 2 and 2 hours of harder work in a 6-hour week.

    SupportsRead
  • peterattiamd.com · 2026

    [20]

    There is no safe gamble with high LDL cholesterol

    Expert article

    Argues that apoB-containing particles drive atherosclerosis whatever the reason they are high, and that lowering them should be based on risk rather than waiting for imaging or symptoms.

    SupportsRead
  • European Heart Journal · 2017

    [11]

    Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

    Expert consensus statement reviewing all evidence types

    A European expert panel concluded from genetic, cohort, Mendelian randomization and trial evidence that LDL particles cause atherosclerotic cardiovascular disease, with risk tied to cumulative exposure.

    SupportsRead
  • Sports Medicine · 2025

    [6]

    Much Ado About Zone 2: A Narrative Review Assessing the Efficacy of Zone 2 Training for Improving Mitochondrial Capacity and Cardiorespiratory Fitness in the General Population.

    Narrative review · Studies in the general population

    Exercise physiologists concluded that current evidence does not support Zone 2 as the optimal intensity for improving mitochondrial or fat-burning capacity, and that higher intensities matter more when training time is limited.

    Finds againstRead

Who follows it, who backs it, who doubts it

Public positions summarized in our words. Follow each link for the full context.

Follow it

  • Peter AttiaPhysician, founder of Early Medical, host of The Drive and author of Outlive

    Created the framework. He describes longevity as lifespan plus healthspan, calls exercise the most potent pro-longevity drug and organizes prevention around the four horsemen.

    peterattiamd.com: Outlive

  • Bill GiffordJournalist and co-author of Outlive

    Co-wrote the book with Attia; a science journalist who previously wrote the aging book Spring Chicken.

    peterattiamd.com: Outlive

Support it

Mixed or cautious

  • Michael BretthauerGastroenterologist and lead investigator of the NordICC colonoscopy trial

    Led the first randomized trial of screening colonoscopy, which found fewer colorectal cancers but no statistically significant drop in colorectal cancer deaths, tempering expectations for aggressive screening.

    New England Journal of Medicine, 2022

  • Andrew SteeleIndependent longevity researcher and author

    Supports research on aging but notes that no medical intervention has yet been proven to extend human life by targeting aging itself, a caution for the drug and supplement tactics in longevity plans.

    Nature, via Scientific American, June 2026

Oppose or doubt it

Peter Attia’s own experiments

Things Peter Attia has tried personally, separate from what the protocol asks others to do and not counted in its rating. 1 testing, 4 kept, 3 stopped.

Public examples

How to follow it

  1. Write your centenarian decathlon: 5 to 10 physical tasks you want to manage in your last decade.
  2. Get a baseline with your clinician: blood pressure, ApoB or LDL cholesterol, Lp(a) once, HbA1c, fasting insulin, and family history for each horseman.
  3. Strength train at least two days a week, including grip and leg work, and add balance and stability exercises.
  4. Build aerobic training to fit your week: with about 2 hours, two interval sessions; with more time, mostly Zone 2 plus one or two harder sessions.
  5. Eat enough protein, around 1.6 g/kg a day for many adults who train, spread over meals, and limit added sugar.
  6. Keep a regular sleep schedule with enough time in bed for 7 or more hours of sleep.
  7. Invest in relationships and mental health, and seek help when emotional health suffers.
  8. Review results every 6 to 12 months and adjust; discuss lipid drugs and screening choices with your clinician.

How to know you are following it

Track weekly minutes in each pillar (stability, strength, Zone 2, VO2max work), protein grams per kg per day and sleep regularity. Measure outcomes a few times a year: a VO2max estimate from a wearable or test, grip strength, body composition, and lab markers for each horseman. AumniVIDA's Attia-style protocol shows where training leans too far toward one pillar.

Common mistakes

  • Doing only Zone 2 and skipping strength, stability and hard intervals.
  • Chasing exact lactate numbers instead of training consistently.
  • Ordering many advanced tests without a plan for acting on the results.
  • Starting lipid or glucose drugs without a prescriber.
  • Treating the book as a fixed protocol rather than a framework to adapt.
  • Neglecting sleep and relationships because they are harder to measure.

Who should be careful

Check with a clinician first if you

  • You have heart disease, chest pain, uncontrolled blood pressure or are new to exercise: get medical clearance before VO2max intervals.
  • You have joint problems or osteoporosis: build stability and strength gradually with a qualified coach or physiotherapist.
  • You have kidney disease: discuss high protein targets with your clinician.
  • You are considering lipid-lowering drugs or other medications for prevention, including any drug Attia has tried on himself: these need a prescriber and monitoring.
  • You are considering extensive screening such as whole-body imaging: discuss false positives and follow-up procedures first.

Possible side effects

  • Training injuries from ramping up intensity or volume too fast.
  • Muscle soreness and fatigue, especially early in strength or interval training.
  • Anxiety and extra procedures from incidental findings on screening tests.
  • Drug side effects, such as muscle symptoms with statins, when medications are used.
  • Time and cost burden of frequent testing and coaching.

Follow it in AumniVIDA

AumniVIDA turns this into scorecards you can follow with your own meals, workouts and labs. Pick the one that fits your goal.

Attia-style longevity

Apply the frameworks Peter Attia describes in Outlive to your own records: the centenarian decathlon, the four horsemen and a stability, strength and aerobic training base, with protein and sugar targets you can track.

The targets

AumniVIDA scores these from your logged meals and measurements, and shows the evidence grade for each protocol.

Targets

  • Protein: at least 1.6 g/kg/day
  • Protein: at least 25 g at most meals
  • Added sugar: at most 5 % of energy

How AumniVIDA follows it with your data

  • Track protein and sugar. The nutrition scorecard follows protein adequacy, protein spread across meals and added sugar.
  • See where your training leans. With workout data from Apple Health or Oura, the coach points out when your training over-indexes on one area, such as plenty of Zone 2 and no strength work.
  • Follow your markers. Put ApoB or LDL, HbA1c, VO2max and resting heart rate on one history, compared with your own baseline.
  • Ask the coach. Ask how your recent results relate to the four horsemen, and get answers that use your data and name their sources.

Follow up to five protocols on the free plan, or the full library with Pro. Rank them, and when two protocols disagree, the higher-ranked one guides the app.

Longevity focus

Eat for lower ApoB and LDL with saturated fat under 10% of energy and plenty of soluble fiber, treat VO2max and strength as longevity markers, and keep labs fresh with a 120-day reminder.

The targets

AumniVIDA scores these from your logged meals and measurements, and shows the evidence grade for each protocol.

Targets

  • Saturated fat: under 10 % of energy
  • Fiber: at least 25 g/day
  • Soluble fiber: at least 5 g/day

How AumniVIDA follows it with your data

  • Track the foods that move lipids. Saturated fat, fiber and soluble fiber are scored every week against your logged meals.
  • Keep your labs current. The protocol flags labs older than 120 days, so your trends stay meaningful.
  • Read results against your trend. A result inside the reference range is not the same as optimal for lifetime risk. The coach frames results against prevention targets and suggests discussing your own targets with your clinician.
  • Count fitness as a marker. Zone 2 volume, VO2max and strength training from your workout data appear alongside your labs.

Follow up to five protocols on the free plan, or the full library with Pro. Rank them, and when two protocols disagree, the higher-ranked one guides the app.

Watch

Talks and explainers worth your time. Nothing loads from YouTube until you press play.

  • Improve Vitality, Emotional & Physical Health & Lifespan | Dr. Peter Attia

    Andrew HubermanOpen on YouTube

    A long interview covering the main Outlive ideas, from the four horsemen to emotional health.

  • 365 ‒ Training for longevity: A roundtable on building strength, preventing injury, protein, & more

    Peter Attia MDOpen on YouTube

    Attia and coaches discuss stability, strength and protein in practice.

  • Building strength and muscle mass: optimize training & nutrition for longevity (AMA #71 rebroadcast)

    Peter Attia MDOpen on YouTube

    Attia's own explanation of the strength pillar and protein needs.

Biomarkers it can move

Common questions

What is the Outlive book about?

Outlive (2023) by Peter Attia with Bill Gifford argues for Medicine 3.0: preventing the four chronic diseases of aging decades early, with exercise as the main tool, plus nutrition, sleep, emotional health and targeted medical care.

What are the four horsemen of Outlive?

Atherosclerotic cardiovascular disease, cancer, neurodegenerative disease such as Alzheimer's, and metabolic disease such as type 2 diabetes. Attia writes that they cause over 80% of deaths in nonsmokers over 50.

What is the centenarian decathlon?

A planning exercise: list the physical tasks you want to manage in your last decade, such as carrying groceries upstairs or lifting a grandchild, and train now with enough margin to keep those abilities as you age.

How much Zone 2 does Peter Attia recommend?

His 2026 guidance depends on time: with about 6 hours a week, about 4 hours of Zone 2 and 2 hours of harder work; with only about 2 hours, two high-intensity sessions with short Zone 2 warm-ups.

What does Outlive say about diet?

It treats the choice of named diet as less important than nutritional biochemistry: enough protein, an energy intake that fits your goals, and adjusting to your own biomarkers. AumniVIDA's Attia-style plan uses at least 1.6 g/kg of protein a day.

What blood tests does Outlive recommend?

The framework emphasizes markers for each horseman, especially apoB and Lp(a) for heart disease and glucose and insulin markers for metabolic health. Which tests suit you is a decision to make with your clinician.

Is Outlive evidence-based?

Its core advice on exercise, strength, LDL lowering and diabetes prevention matches strong evidence. Some specifics, such as the special role of Zone 2, very early lipid drugs in low-risk people and extensive screening, go beyond what trials show.

Does Peter Attia take rapamycin?

He has said he began taking rapamycin around 2018. In October 2026 he described growing uncertainty about it, citing strong animal data but unresolved human dosing. It is a personal experiment, listed below with his other tries, not something Outlive asks readers to do.

Why did Peter Attia stop long fasts?

For about three years he did water-only fasts of up to 10 days. A DEXA scan in the fall of 2021 showed far less muscle than a decade earlier, which he blamed mainly on fasting, so he shifted to more protein and strength training.

Has Peter Attia endorsed this page or AumniVIDA?

No. Attia has not reviewed or endorsed this page or AumniVIDA's Attia-style protocol, which is compiled from his published frameworks.

Sources

  1. 1.Attia P, Gifford B. Outlive: The Science and Art of Longevity. Book, 2023. Link
  2. 2.Mandsager K, Harb S, Cremer P, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 2018. doi:10.1001/jamanetworkopen.2018.3605
  3. 3.Cholesterol Treatment Trialists' (CTT) Collaboration; Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. The Lancet, 2010. doi:10.1016/S0140-6736(10)61350-5
  4. 4.Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. Journal of the American College of Cardiology, 2012. doi:10.1016/j.jacc.2012.09.017
  5. 5.Milanović Z, Sporiš G, Weston M. Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. Sports Medicine, 2015. doi:10.1007/s40279-015-0365-0
  6. 6.Storoschuk KL, Moran-MacDonald A, Gibala MJ, Gurd BJ. Much Ado About Zone 2: A Narrative Review Assessing the Efficacy of Zone 2 Training for Improving Mitochondrial Capacity and Cardiorespiratory Fitness in the General Population. Sports Medicine, 2025. doi:10.1007/s40279-025-02261-y
  7. 7.Bretthauer M, Løberg M, Wieszczy P, et al. Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. New England Journal of Medicine, 2022. doi:10.1056/NEJMoa2208375
  8. 8.Stensvold D, Viken H, Steinshamn SL, et al. Effect of exercise training for five years on all cause mortality in older adults-the Generation 100 study: randomised controlled trial. BMJ, 2020. doi:10.1136/bmj.m3485
  9. 9.Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA, 2009. doi:10.1001/jama.2009.681
  10. 10.Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine, 2022. doi:10.1136/bjsports-2021-105061
  11. 11.Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 2017. doi:10.1093/eurheartj/ehx144
  12. 12.Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. New England Journal of Medicine, 2017. doi:10.1056/NEJMoa1615664
  13. 13.San-Millán I, Brooks GA. Assessment of Metabolic Flexibility by Means of Measuring Blood Lactate, Fat, and Carbohydrate Oxidation Responses to Exercise in Professional Endurance Athletes and Less-Fit Individuals. Sports Medicine, 2018. doi:10.1007/s40279-017-0751-x
  14. 14.Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine, 2018. doi:10.1136/bjsports-2017-097608
  15. 15.Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 2015. doi:10.1016/S0140-6736(14)62000-6
  16. 16.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002. doi:10.1056/NEJMoa012512
  17. 17.Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep, 2010. doi:10.1093/sleep/33.5.585
  18. 18.Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Medicine, 2010. doi:10.1371/journal.pmed.1000316
  19. 19.Nelson N, Yeater T, Attia P. A better way to think about Zone 2. peterattiamd.com, 2026. Link
  20. 20.Dayspring T, Attia P, et al. There is no safe gamble with high LDL cholesterol. peterattiamd.com, 2026. Link
  21. 21.Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 2009. doi:10.1038/nature08221
  22. 22.Konopka AR, Laurin JL, Schoenberg HM, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell, 2019. doi:10.1111/acel.12880

AumniVIDA explains health data for general wellness. Talk to your clinician about your own results, medication and diagnosis.

AumniVIDA explains health information for general wellness. Talk to your clinician before changing your diet, training or medication for a health condition.

Follow outlive and medicine 3.0 (peter attia) with your own data.

Log meals, connect your wearable and add your lab reports. AumniVIDA scores the protocols you choose each week and shows what changed. Join the iPhone beta.

Join the iPhone beta. We send TestFlight invitations in batches.